研究园简易版
·
经典书籍
·
期刊文章
·
有原文
·
完整版(可多选筛选、搜索)
·
首页
搜索
2017 年 · Diagnostics & Prediction(诊断与预测)
64 篇,新的在前。点标题看作者和摘要。
回到 2017 年
A Bayesian framework for performance assessment and comparison of imaging biomarker quantification methods
· SMMR · 2017-12-22 · 在第 1 页
Time‐to‐event data with time‐varying biomarkers measured only at study entry, with applications to Alzheimer's disease
· SiM · 2017-12-20 · 在第 1 页
A multiple‐model generalisation of updating clinical prediction models
· SiM · 2017-12-18 · 在第 1 页
Determining the likely place of HIV acquisition for migrants in Europe combining subject-specific information and biomarkers data
· SMMR · 2017-12-12 · 在第 2 页
Dynamic prediction in functional concurrent regression with an application to child growth
· SiM · 2017-12-11 · 在第 2 页
Relative efficiency of precision medicine designs for clinical trials with predictive biomarkers
· SiM · 2017-12-04 · 在第 2 页
An R2‐curve for evaluating the accuracy of dynamic predictions
· SiM · 2017-12-04 · 在第 2 页
Sample size requirements for learning to classify with high-dimensional biomarker panels
· SMMR · 2017-11-28 · 在第 3 页
Estimating diagnostic accuracy for clustered ordinal diagnostic groups in the three-class case—Application to the early diagnosis of Alzheimer disease
· SMMR · 2017-11-28 · 在第 3 页
Futility for subgroup analyses in the adaptive signature design
· SMMR · 2017-11-27 · 在第 3 页
Measurement error correction in the least absolute shrinkage and selection operator model when validation data are available
· SMMR · 2017-11-23 · 在第 3 页
First things first: risk model performance metrics should reflect the clinical application
· SiM · 2017-11-20 · 在第 3 页
Clinical risk reclassification at 10 years
· SiM · 2017-11-20 · 在第 4 页
Biomarker combinations for diagnosis and prognosis in multicenter studies: Principles and methods
· SMMR · 2017-11-20 · 在第 4 页
Improved Dynamic Predictions from Joint Models of Longitudinal and Survival Data with Time-varying Effects Using P-splines
· Biometrics · 2017-11-01 · 在第 5 页
Efficientℓ0‐norm feature selection based on augmented and penalized minimization
· SiM · 2017-10-30 · 在第 5 页
Combining multiple biomarkers linearly to maximize the partial area under the ROC curve
· SiM · 2017-10-30 · 在第 5 页
Risk Prediction for Heterogeneous Populations with Application to Hospital Admission Prediction
· Biometrics · 2017-10-26 · 在第 5 页
Sensitivity analysis for publication bias in meta‐analysis of diagnostic studies for a continuous biomarker
· SiM · 2017-10-09 · 在第 6 页
Simultaneous inference for factorial multireader diagnostic trials
· SiM · 2017-10-05 · 在第 6 页
Meta‐analytical synthesis of regression coefficients under different categorization scheme of continuous covariates
· SiM · 2017-08-16 · 在第 9 页
Evaluating disease prediction models using a cohort whose covariate distribution differs from that of the target population
· SMMR · 2017-08-16 · 在第 9 页
Notes on the overlap measure as an alternative to the Youden index: How are they related?
· SiM · 2017-08-15 · 在第 9 页
Inference for multimarker adaptive enrichment trials
· SiM · 2017-08-10 · 在第 9 页
Estimation of smooth ROC curves for biomarkers with limits of detection
· SiM · 2017-08-07 · 在第 10 页
On comparing 2 correlated C indices with censored survival data
· SiM · 2017-07-31 · 在第 11 页
Model-free Scoring System for Risk Prediction with Application to Hepatocellular Carcinoma Study
· Biometrics · 2017-07-25 · 在第 11 页
A semiparametric method for comparing the discriminatory ability of biomarkers subject to limit of detection
· SiM · 2017-07-25 · 在第 11 页
Two-way partial AUC and its properties
· SMMR · 2017-07-14 · 在第 11 页
Bayesian Phase I/II Biomarker-Based Dose Finding for Precision Medicine With Molecularly Targeted Agents
· JASA · 2017-07-13 · 在第 12 页
Reporting guidelines for diagnostic accuracy studies that use Bayesian latent class models (STARD‐BLCM)
· SiM · 2017-07-04 · 在第 12 页
Evaluating Principal Surrogate Markers in Vaccine Trials in the Presence of Multiphase Sampling
· Biometrics · 2017-06-26 · 在第 13 页
Landmark cure rate models with time-dependent covariates
· SMMR · 2017-06-19 · 在第 13 页
Asymptotic distribution of ∆AUC, NRIs, and IDI based on theory of U‐statistics
· SiM · 2017-06-19 · 在第 13 页
On Theoretically Optimal Ranking Functions in Bipartite Ranking
· JASA · 2017-06-13 · 在第 14 页
Bayesian Calibration of Inexact Computer Models
· JASA · 2017-06-13 · 在第 14 页
Predictive inference for best linear combination of biomarkers subject to limits of detection
· SiM · 2017-05-28 · 在第 15 页
A score test for genetic class‐level association with nonlinear biomarker trajectories
· SiM · 2017-05-23 · 在第 15 页
Comparing and combining biomarkers as principal surrogates for time‐to‐event clinical endpoints
· SiM · 2017-05-22 · 在第 15 页
Expected p -values in light of an ROC curve analysis applied to optimal multiple testing procedures
· SMMR · 2017-05-15 · 在第 15 页
Modeling qRT-PCR dynamics with application to cancer biomarker quantification
· SMMR · 2017-05-14 · 在第 15 页
P‐value calibration in multiple hypotheses testing
· SiM · 2017-05-10 · 在第 16 页
Meta-analysis of prediction model performance across multiple studies: Which scale helps ensure between-study normality for the C -statistic and calibration measures?
· SMMR · 2017-05-08 · 在第 16 页
A Bayesian Screening Approach for Hepatocellular Carcinoma Using Multiple Longitudinal Biomarkers
· Biometrics · 2017-05-08 · 在第 16 页
Bayesian Treed Calibration: An Application to Carbon Capture With AX Sorbent
· JASA · 2017-05-03 · 在第 17 页
Pattern mixture models for clinical validation of biomarkers in the presence of missing data
· SiM · 2017-05-02 · 在第 17 页
A comparison of risk prediction methods using repeated observations: an application to electronic health records for hemodialysis
· SiM · 2017-05-02 · 在第 17 页
Patient subgroup identification for clinical drug development
· SiM · 2017-04-30 · 在第 17 页
Simulation-based adjustment after exploratory biomarker subgroup selection in phase II
· SiM · 2017-04-24 · 在第 18 页
Analysis of Multiple Diverse Phenotypes via Semiparametric Canonical Correlation Analysis
· Biometrics · 2017-04-13 · 在第 18 页
A general framework for the regression analysis of pooled biomarker assessments
· SiM · 2017-03-28 · 在第 20 页
Sensitivity Analysis for Matched Pair Analysis of Binary Data: From Worst Case to Average Case Analysis
· Biometrics · 2017-03-27 · 在第 20 页
Optimal quantile level selection for disease classification and biomarker discovery with application to electrocardiogram data
· SMMR · 2017-03-17 · 在第 20 页
Estimation of treatment effect in two-stage confirmatory oncology trials of personalized medicines
· SiM · 2017-03-17 · 在第 20 页
Augmented Estimation for t-Year Survival with Censored Regression Models
· Biometrics · 2017-03-10 · 在第 21 页
Combining biomarkers for classification with covariate adjustment
· SiM · 2017-03-09 · 在第 21 页
Bayesian Population Finding with Biomarkers in a Randomized Clinical Trial
· Biometrics · 2017-03-03 · 在第 21 页
Corrected ROC analysis for misclassified binary outcomes
· SiM · 2017-02-28 · 在第 21 页
Quantitative imaging biomarkers: Effect of sample size and bias on confidence interval coverage
· SMMR · 2017-02-27 · 在第 21 页
Bayesian Response-Adaptive Designs for Basket Trials
· Biometrics · 2017-02-17 · 在第 22 页
Penalized Nonlinear Mixed Effects Model to Identify Biomarkers That Predict Disease Progression
· Biometrics · 2017-02-09 · 在第 23 页
Biomarker validation with an imperfect reference: Issues and bounds
· SMMR · 2017-02-06 · 在第 23 页
Dynamic predictions using flexible joint models of longitudinal and time‐to‐event data
· SiM · 2017-01-22 · 在第 24 页
Personalized dynamic prediction of death according to tumour progression and high-dimensional genetic factors: Meta-analysis with a joint model
· SMMR · 2017-01-16 · 在第 25 页